GAMA
TEVA icon

Graticule Asia Macro Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Graticule Asia Macro Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Buy
+336
New +$11.2K ﹤0.01% 196

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Graticule Asia Macro Advisors's TEVA Position: Q2 2026 in Review

Graticule Asia Macro Advisors opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 336 shares worth $11.4K. The stake represents ﹤0.01% of the portfolio and ranks #196 among its holdings.

676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Graticule Asia Macro Advisors held 336 shares of Teva Pharmaceutical Industries Limited worth $11.4K as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new Graticule Asia Macro Advisors position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Graticule Asia Macro Advisors's portfolio in Q2 2026, its #196 holding.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.